Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022
Open Access
- 29 April 2022
- journal article
- research article
- Published by Centers for Disease Control MMWR Office in Morbidity and Mortality Weekly Report (MMWR)
- Vol. 71 (17), 606-608
- https://doi.org/10.15585/mmwr.mm7117e3
Abstract
This report describes the increase in infection-induced antibodies against COVID-19 during Omicron predominance.Keywords
This publication has 7 references indexed in Scilit:
- Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022Morbidity and Mortality Weekly Report (MMWR), 2022
- Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022Morbidity and Mortality Weekly Report (MMWR), 2022
- Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regressionThe Lancet, 2022
- Anticoagulation in COVID-19The Lancet, 2021
- Risk Perception, Preventive Behavior, and Medical Care Avoidance among American Older Adults During the COVID-19 PandemicJournal of Aging and Health, 2021
- Practical Considerations in Raking Survey DataSurvey Practice, 2009
- Bootstrap Methods: Another Look at the JackknifeThe Annals of Statistics, 1979